openPR Logo
Press release

Clinical Reference Laboratory Market Valued At US$ 234.5 Billion In 2023

10-10-2023 12:36 PM CET | Health & Medicine

Press release from: Fact.MR

Clinical Reference Laboratory Market Valued At US$ 234.5

By the end of 2033, the market for clinical reference laboratories is anticipated to have grown consistently at a CAGR of 5.8%, reaching US$ 412 billion. Clinical specimens obtained from patients are examined in a laboratory setting during clinical pathology tests to learn more about their health condition, help with the identification and diagnosis of disorders and direct treatment choices.

The market for clinical reference laboratories is predicted to grow more quickly as a result of the increasing emphasis on molecular biology. Both the development of the area of microbiology and the growth of bio-reference laboratories are anticipated to increase demand for clinical reference laboratories. Additionally, the business is anticipated to benefit significantly from the rising investment in laboratory services.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8520?PS

The market is being driven by the increasing prevalence of chronic and infectious illnesses as well as the rising demand for precise and expedient disease diagnosis methods. Globally, the burden of chronic diseases and infectious diseases is continually rising. Demand for clinical diagnostic tests is increasing due to the rising incidence of diseases such as cancer and tuberculosis. Diagnostic tests are one of the most accurate ways to identify and characterize biomarkers of chronic diseases and to detect the presence of pathogens.

For instance, a WHO update estimates that as of 2021, 10 million individuals worldwide have tuberculosis, of which, 5.6 million men, 3.3 million women, and 1.1 million children were affected.
Increased prevalence of such disorders across the world is projected to boost the demand for clinical care, thereby leading to higher need for clinical reference laboratory services.

๐Š๐ž๐ฒ ๐“๐š๐ค๐ž๐š๐ฐ๐š๐ฒ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ

The global clinical reference laboratory market is valued at US$ 234.5 billion in 2023.
Demand for clinical reference laboratory services is projected to rise at a CAGR of 5.8% during the forecast period (2023 to 2033).
The global market is projected to touch US$ 412 billion by 2033.
North America accounts for 35% share of the global clinical reference laboratory market in 2023.
Demand for clinical reference laboratory services in Asia Pacific is projected to rise at a CAGR of 4.8% through.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ -
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8520

๐–๐ข๐ง๐ง๐ข๐ง๐  ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ

To expand their consumer base, key players are employing various strategies such as mergers and acquisitions, in response to the increasing efforts. These strategies are expected to intensify market competition in the near future. The rising incidence of chronic diseases among the expanding population is expected to drive demand for these services and draw more players to the market.

In December 2020, TriCore Reference Laboratories, an independent clinical reference laboratory supported by Presbyterian Healthcare Services and the University of New Mexico Health Sciences Centre, opened a new branch lab at New Mexico State University. This facility has already processed more than 15,000 COVID-19 tests to date.

๐Š๐ž๐ฒ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐๐ซ๐จ๐Ÿ๐ข๐ฅ๐ž๐

OPKO Health Inc.
Quest Diagnostics Incorporated
Myriad Genetics
LabCorp
NeoGenomics
Unilabs
Sonic HealthCare Limited
KingMed Diagnostics
SYNAB International GmbH
ARUP Laboratories

๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐‘๐ž๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž ๐‹๐š๐›๐จ๐ซ๐š๐ญ๐จ๐ซ๐ฒ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

By Type :

Standalone
Clinical-based
Hospital-based

By Application :

Clinical Trials
Laboratory Medicine

By Region :

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

๐Œ๐จ๐ซ๐ž ๐•๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐จ๐ง ๐Ž๐Ÿ๐Ÿ๐ž๐ซ

Fact.MR, in its new offering, presents an unbiased analysis of the global clinical reference laboratory market, presenting historical demand data for 2018 to 2022 and forecast statistics for 2023 to 2033.

The study divulges essential insights on the market based on type (standalone, clinical-based, hospital-based) and application (clinical trials, laboratory medicine), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

Contact:
Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Reference Laboratory Market Valued At US$ 234.5 Billion In 2023 here

News-ID: 3242957 • Views: โ€ฆ

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโ€ฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โ€ฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโ€ฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโ€ฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โ€ฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโ€ฆ

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,โ€ฆ
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primaryโ€ฆ
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portionโ€ฆ
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial โ€ฆ
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medicalโ€ฆ
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum forโ€ฆ
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog โ€ฆ
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360ยฐ view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinicalโ€ฆ